Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.71 |
| ▸ | AKR1B1 | P15121 | 6/20 | 0.71 |
| ▸ | P4HB | P07237 | 5/20 | 0.71 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.71 |
| ▸ | MAOA | P21397 | 4/20 | 0.71 |
| ▸ | XDH | P47989 | 4/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.71 |
| ▸ | SLCO2B1 | O94956 | 3/20 | 0.71 |
| ▸ | PIM2 | Q9P1W9 | 2/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | CA12 | O43570 | 2/20 | 0.71 |
| ▸ | CA2 | P00918 | 2/20 | 0.71 |
| ▸ | CA4 | P22748 | 2/20 | 0.71 |
| ▸ | CA7 | P43166 | 2/20 | 0.71 |
| ▸ | GAA | P10253 | 7/20 | 0.69 |
| ▸ | POLB | P06746 | 6/20 | 0.69 |
| ▸ | MAPT | P10636 | 6/20 | 0.69 |
| ▸ | ALPI | P09923 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Reynoutrin SCHEMBL31130799 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL14350762 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL3641504 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL4226891 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL38138 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL5590747 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL20298285 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL6759025 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL6119167 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA | |
| Reynoutrin SCHEMBL28550462 | 1.00 | KDM4E (0.71) | KDM4EAKR1B1P4HBEPHX2MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115449798-A | Acer truncatum leaf steel corrosion inhibitor and preparation method thereof | 北京科技大学 | 2022-12-09 | — | — | CN | claimed |
| CN-113080268-A | Purple tea and purple tea extract with antioxidant and/or hypoglycemic activities, and preparation method and application thereof | 中国科学院昆明植物研究所 | 2021-07-09 | — | — | CN | claimed |
| EP-3413727-A1 | COMPOSITION CONTAINING GUAIJAVERIN FOR REDUCING AND/OR SUPPRESSING AN INTESTINAL GLUCOSE RESORPTION, NUTRITIONAL SUPPLEMENT, USE OF THE COMPOSITION AND PROCESS FOR PRODUCING THE NUTRITIONAL SUPPLEMENT | PM-International AG (LU) | 2018-12-19 | — | — | EP | claimed |
| WO-2017137405-A1 | COMPOSITION CONTAINING GUAIJAVERIN FOR REDUCING AND/OR SUPPRESSING AN INTESTINAL GLUCOSE RESORPTION, NUTRITIONAL SUPPLEMENT, USE OF THE COMPOSITION AND PROCESS FOR PRODUCING THE NUTRITIONAL SUPPLEMENT | PM-INTERNATIONAL AG (LU) | 2017-08-17 | — | — | WO | claimed |
| EP-3052202-A1 | SKIN TANNING EXTRACT | DSM IP Assets B.V. (NL) | 2016-08-10 | — | — | EP | claimed |
| WO-2015049366-A1 | SKIN TANNING EXTRACT | DSM IP ASSETS B.V. (NL) | 2015-04-09 | — | — | WO | claimed |
| CN-118225913-A | Method for detecting multiple components in aizoon stonecrop based on UPLC-QTOF-MS | 江阴天江药业有限公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-115449798-A | Acer truncatum leaf steel corrosion inhibitor and preparation method thereof | 北京科技大学 | 2022-12-09 | — | — | CN | disclosed |
| CN-113080268-A | Purple tea and purple tea extract with antioxidant and/or hypoglycemic activities, and preparation method and application thereof | 中国科学院昆明植物研究所 | 2021-07-09 | — | — | CN | disclosed |
| EP-3780974-A1 | GUAVA EXTRACT | PM-International AG (LU) | 2021-02-24 | — | — | EP | disclosed |
| WO-2019201425-A1 | GUAVA EXTRACT | PM-INTERNATIONAL AG (LU) | 2019-10-24 | — | — | WO | disclosed |
| US-10293013-B2 | Water soluble Psidium guajava leaf extract having standardized phytochemicals | PHYTOTECH EXTRACTS PVT LTD (IN) | 2019-05-21 | — | — | US | disclosed |
| US-20170080039-A1 | WATER SOLUBLE PSIDIUM GUAJAVA LEAF EXTRACT HAVING STANDARDIZED PHYTOCHEMICALS | PHYTOTECH EXTRACTS PVT LTD (IN) | 2017-03-23 | — | — | US | disclosed |
| EP-3052202-A1 | SKIN TANNING EXTRACT | DSM IP Assets B.V. (NL) | 2016-08-10 | — | — | EP | disclosed |
| WO-2015136454-A1 | WATER SOLUBLE PSIDIUM GUAJAVA LEAF EXTRACT HAVING STANDARDIZED PHYTOCHEMICALS | PHYTOTECH EXTRACTS PVT LTD (IN) | 2015-09-17 | — | — | WO | disclosed |
| WO-2015049366-A1 | SKIN TANNING EXTRACT | DSM IP ASSETS B.V. (NL) | 2015-04-09 | — | — | WO | disclosed |
| WO-2015016428-A1 | ANTIVIRAL COMPOSITION FOR FISH CONTAINING QUERCETIN AS ACTIVE INGREDIENT | 한국기초과학지원연구원 (KR) | 2015-02-05 | — | — | WO | disclosed |
| EP-2144621-A2 | GUAVA EXTRACT | OMNICA GMBH (DE) | 2010-01-20 | — | — | EP | disclosed |
| WO-2009027849-A2 | GUAVA EXTRACT | OMNICA GMBH (US) | 2009-03-05 | — | — | WO | disclosed |
| US-20080293644-A1 | GUAVA EXTRACT | OMNICA GMBH (DE) | 2008-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293644-A1 | GUAVA EXTRACT | DPP4, DPP8, DPP3 | KDM4E 529/4885AKR1B1 3307/4885P4HB 1667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.